Airway management

Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study

BMJPublished Retrospective cohort study

Main finding · Pulmonary aspirationResult — go to the resultPooled relative risk 0.98 95% CI 0.73–1.31

Authors' conclusion

In this comparative cohort study, no increased risk of pulmonary aspiration during upper gastrointestinal endoscopy was observed among adults with type 2 diabetes using GLP-1 receptor agonists compared with SGLT-2 inhibitors within 30 days of the procedure; however, GLP-1 receptor agonists were associated with a higher risk of discontinuation of endoscopy, possibly owing to a higher risk of retained gastric content.

Study context

Population
Adults (≥18 years) with type 2 diabetes undergoing upper gastrointestinal endoscopy
Participants
43,365 adults
Exposure
GLP-1 receptor agonist vs SGLT-2 inhibitor
  • GLP-1 receptor agonistn = 24,817
  • SGLT-2 inhibitorn = 18,537reference
Outcome
Pulmonary aspiration (defined using diagnostic codes)
Follow-up
Day of or day after endoscopy
Methodological detailscomparative cohort, propensity-score fine stratification weighting, two US commercial healthcare databases
  • Comparative cohort
  • Propensity-score fine stratification weighting
  • Two US commercial healthcare databases

Main finding

Pulmonary aspiration

Pooled relative risk

0.98

95% CI 0.73–1.31

By group

GLP-1 receptor agonist vs SGLT-2 inhibitor
pooled RR 0.98 (95% CI 0.73–1.31)

As reported in the abstract

Observational data: associations, not effects.

Secondary outcomes

OutcomeGLP-1 receptor agonistSGLT-2 inhibitorPooled RR (95% CI)
Discontinuation of endoscopyweighted risk per 1000 people 9.79 per 1000 peopleweighted risk per 1000 people 4.91 per 1000 people1.99 (1.56–2.53)

Original publication

Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study. BMJ. Published 22 October 2024. doi:10.1136/bmj-2024-080340

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.